Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.
作者信息
Meyer Emily J, Mignone Edward, Hade Anthony, Thiruvenkatarajan Venkatesan, Bryant Robert V, Jesudason David
机构信息
Department of Endocrinology and Diabetes, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
出版信息
Diabetes Care. 2020 Nov;43(11):e181-e184. doi: 10.2337/dc20-1244. Epub 2020 Sep 17.
Abstract
摘要
相似文献
1
Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.结肠镜检查期间与钠-葡萄糖协同转运蛋白2抑制剂治疗相关的围手术期正常血糖性糖尿病酮症酸中毒
Diabetes Care. 2020 Nov;43(11):e181-e184. doi: 10.2337/dc20-1244. Epub 2020 Sep 17.
2
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.与钠-葡萄糖协同转运蛋白2抑制剂使用相关的正常血糖性糖尿病酮症酸中毒：一例病例报告及文献综述
Int J Emerg Med. 2019 Sep 5;12(1):27. doi: 10.1186/s12245-019-0240-0.
3
Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis.急性心肌梗死并发钠-葡萄糖协同转运蛋白2抑制剂相关酮症酸中毒导致的心搏骤停。
J Cardiol Cases. 2016 Nov 14;15(2):56-60. doi: 10.1016/j.jccase.2016.10.006. eCollection 2017 Feb.
4
Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.一名27岁1型糖尿病女性患者使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂卡格列净治疗后出现正常血糖性糖尿病酮症酸中毒。
Pak J Med Sci. 2016 May-Jun;32(3):786-8. doi: 10.12669/pjms.323.9201.
5
SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.钠-葡萄糖协同转运蛋白2抑制剂所致正常血糖性糖尿病酮症酸中毒：一例报告
Kidney Med. 2020 Feb 22;2(2):218-221. doi: 10.1016/j.xkme.2019.12.006. eCollection 2020 Mar-Apr.
6
Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.减重手术后使用钠-葡萄糖协同转运蛋白2抑制剂导致的正常血糖性糖尿病酮症酸中毒：文献综述
Cureus. 2020 Oct 10;12(10):e10878. doi: 10.7759/cureus.10878.
7
Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.一名服用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的患者出现丙酮升高的正常血糖性糖尿病酮症酸中毒。
J Emerg Med. 2017 Feb;52(2):223-226. doi: 10.1016/j.jemermed.2016.07.082. Epub 2016 Oct 4.
8
Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors.血糖正常的代谢性酮症酸中毒：钠-葡萄糖协同转运蛋白2抑制剂的一种罕见并发症。
SAGE Open Med Case Rep. 2016 Nov 24;4:2050313X16675259. doi: 10.1177/2050313X16675259. eCollection 2016.
9
Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.与钠-葡萄糖协同转运蛋白2抑制剂卡格列净相关的伴有长期糖尿的正常血糖性糖尿病酮症酸中毒
J Investig Med High Impact Case Rep. 2017 Jun 8;5(2):2324709617712736. doi: 10.1177/2324709617712736. eCollection 2017 Apr-Jun.
10
When Guidelines Fail: Euglycemic Diabetic Ketoacidosis After Bariatric Surgery in a Patient Taking a Sodium-Glucose Cotransporter-2 Inhibitor: A Case Report.指南失效时：一名服用钠-葡萄糖协同转运蛋白2抑制剂的患者在减重手术后发生正常血糖性糖尿病酮症酸中毒：一例报告
A A Pract. 2018 Jul 15;11(2):46-48. doi: 10.1213/XAA.0000000000000734.
引用本文的文献
1
A case of perioperative euglycemic ketoacidosis in a patient without diabetes: are current guidelines enough?一例非糖尿病患者围手术期正常血糖性酮症酸中毒：现行指南是否足够？
Perioper Med (Lond). 2025 Jul 4;14(1):68. doi: 10.1186/s13741-025-00548-2.
2
Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.过去二十年研发的降糖药物及其围手术期影响
Pharmaceuticals (Basel). 2024 Dec 24;18(1):4. doi: 10.3390/ph18010004.
3
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂相关正常血糖性酮症酸中毒高危人群择期手术延续的新方法
Diabetes Spectr. 2024 Spring;37(2):165-169. doi: 10.2337/ds23-0040. Epub 2024 Mar 15.
4
Perioperative DKA linked to SGLT2i Therapy: The enigmas of preprocedural handling, diagnosis, and event rate estimation.围手术期糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂治疗相关：术前处理、诊断及事件发生率估计的谜团
Ann Card Anaesth. 2023 Jul-Sep;26(3):361-362. doi: 10.4103/aca.aca_183_22.
5
Preparing for Colonoscopy in People with Diabetes: A Review with Suggestions for Clinical Practice.糖尿病患者的结肠镜检查准备：临床实践回顾与建议
J Can Assoc Gastroenterol. 2022 Dec 30;6(1):26-36. doi: 10.1093/jcag/gwac035. eCollection 2023 Feb.
6
Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.钠-葡萄糖共转运蛋白 2 抑制剂与二肽基肽酶 4 抑制剂和磺脲类药物治疗糖尿病酮症酸中毒的安全性比较。
Diabetes Care. 2022 Apr 1;45(4):919-927. doi: 10.2337/dc21-2177.
7
SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.在一个多中心队列中，SGLT-2 抑制剂与血糖正常和高血糖性 DKA 相关。
Sci Rep. 2021 May 13;11(1):10293. doi: 10.1038/s41598-021-89752-w.
本文引用的文献
1
Antihyperglycemic therapy during colonoscopy preparation: A review and suggestions for practical recommendations.结肠镜检查准备期间的降血糖治疗：综述及实用建议。
United European Gastroenterol J. 2019 Jul;7(6):735-740. doi: 10.1177/2050640619846365. Epub 2019 Apr 20.
2
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.与钠-葡萄糖共转运蛋白 2 抑制剂相关的围手术期糖尿病酮症酸中毒：系统评价。
Br J Anaesth. 2019 Jul;123(1):27-36. doi: 10.1016/j.bja.2019.03.028. Epub 2019 May 3.
3
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
4
SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.钠-葡萄糖协同转运蛋白2抑制剂相关的正常血糖性糖尿病酮症酸中毒：南澳大利亚州临床病例系列及澳大利亚自发不良事件通报
Diabetes Care. 2018 Apr;41(4):e47-e49. doi: 10.2337/dc17-1721. Epub 2018 Feb 13.
5
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
Zotero 插件